Pomalidomide-C7-COOH

• CAT Number: I014007
• CAS Number: 2225940-51-0
• Molecular Formula: C21H25N3O6
• Molecular Weight: 415.44
• Purity: ≥95%
• Synonyms: 8-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]octanoic acid
• InChI: InChI=1S/C21H25N3O6/c25-16-11-10-15(19(28)23-16)24-20(29)13-7-6-8-14(18(13)21(24)30)22-12-5-3-1-2-4-9-17(26)27/h6-8,15,22H,1-5,9-12H2,(H,26,27)(H,23,25,28)
• InChIKey: IJDAOSIFULSGHH-UHFFFAOYSA-N
• SMILES: C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)NCCCCCCCC(=O)O

Pomalidomide-C7-COOH(CAT: I014007) is a chemical derivative of pomalidomide, designed for use in advanced pharmaceutical research, particularly in the study of targeted therapies and drug conjugates. The C7-COOH modification introduces a carboxylic acid functional group seven carbon atoms away from the core pomalidomide structure, allowing for conjugation with various biomolecules, such as antibodies or peptides. This derivative is valuable in the development of antibody-drug conjugates (ADCs) and other targeted therapeutic platforms, where precise attachment of the active drug to a targeting molecule is required. Pomalidomide itself is known for its immunomodulatory and anti-cancer properties, and this derivative retains those effects while enabling further customization for specialized therapeutic applications.